Vitamina D en la encefalopatía hipóxico isquémica neonatal

1] Juul, S.E.; Comstock, B.A.; Heagerty, P.J.; Mayock, D.E.; Goodman, A.M.; Hauge, S.; Gonzalez, F.; Wu, Y.W. High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial - Background, Aims, and Study Protocol. Neonatology, 2018, 113(4), 331-338.

[2] Sun, H.; Juul, H.M.; Jensen, F.E. Models of hypoxia and ischemiainduced seizures. J. Neurosci. Methods, 2016, 260, 252-260.

[3] Chalak, L.; Latremouille, S.; Mir, I.; Sanchez, P.J.; Sant'Anna, G. A review of the conundrum of mild hypoxic-ischemic encephalopathy: Current challenges and moving forward. Early Hum. Dev., 2018, 120, 88-94.

[4] Zaigham, M.; Lundberg, F.; Olofsson, P. Protein S100B in umbilical cord blood as a potential biomarker of hypoxic-ischemic encephalopathy in asphyxiated newborns. Early Hum. Dev., 2017, 112, 48-53.

[5] Muengtaweepongsa, S.; Srivilaithon, W. Targeted temperature management in neurological intensive care unit. World J Methodol. 2017, 7(2), 55-67.

[6] Martinello, K.; Hart, A.R.; Yap, S.; Mitra, S.; Robertson, N.J. Management and investigation of neonatal encephalopathy: 2017 update. Arch. Dis. Child Fetal Neonatal Ed., 2017, 102(4), F346-F358.

[7] Chaparro-Huerta, V.; Flores-Soto, M.E.; Merin Sigala, M.E.; Barrera, D.E.; Leon, J.C.; Lemus-Varela, M.L.; Torres-Mendoza, B.M.; Beas-Zarate, C. Proinflammatory Cytokines, Enolase and S-100 as Early Biochemical Indicators of Hypoxic-Ischemic Encephalopathy Following Perinatal Asphyxia in Newborns. Pediatr Neonatol., 2017, 58(1), 70-76.

[8] Beharier, O.; Kahn, J.; Shusterman, E.; Sheiner, E. S100B - a potential biomarker for early detection of neonatal brain damage following asphyxia. J. Matern. Fetal Neonatal. Med., 2012, 25, 1523-1528.

[9] Yildiz, E.P.; Ekici, B.; Tatli, B. Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment. Expert Rev. Neurother., 2017, 17(5), 449-459. [10] Bell, S.G. Hypoxic-Ischemic Encephalopathy and Serum Magnesium Monitoring and Maintenance. Neonatal Netw., 2016, 35(3),159-163.

[11] Yvonne, W.W.U.; Fernando, F. Gonzale. Erythropoietin: A novel therapy for hypoxic-ischaemic encephalopathy? Dev. Med. Child Neurol., 2015, 57(S3), 34-39.

[12] Stessman, L.E.; Peeples, E.S. Vitamin D and Its Role in Neonatal Hypoxic-Ischemic Brain Injury. Neonatology, 2018, 113(4), 305-312.

[13] Mia, A.H.; Akter, K.R.; Rouf, M.A.; Islam, M.N.; Hoque, M.M.; Hossain, M.A.; Chowdhury, A.K. Grading of perinatal asphyxia by clinical parameters and agreement between this grading and Sarnat & Sarnat stages without measures. Mymensingh Med. J., 2013,  22(4), 807-813.

[14] Anderson-Berry, A.; Thoene, M.; Wagner, J.; Lyden, E.; Jones, G.; Kaufmann, M.; Van Ormer, M.; Hanson, C. Randomized trial of two doses of vitamin D3 in preterm infants <32 weeks: Dose impact on achieving desired serum 25(OH)D3 in a NICU population. PLoS One, 2017, 12(10), e0185950.

[15] Elmahdy, H.; El-Mashad, A.R.; El-Bahrawy, H.; El-Gohary, T.; El-Barbary, A.; Aly, H. Human recombinant erythropoietin in asphexia neonatorum: Pilot trial. Pediatrics, 2010, 125(5), e1135-e1142.

[16] Gathwala, G.; Khera, A.; Singh, I. Magnesium therapy in birth asphyxia. Indian J. Pediatr., 2006, 73(3), 209-212.

[17] Elliott, J.P.; Morrison, J.C.; Bofill, J.A. Risks and Benefits of Magnesium Sulfate Tocolysis in Preterm Labor (PTL). AIMS Public Health, 2016, 3(2), 348-356.

[18] Kleinman, M.E.; Chameides, L.; Schexnayder, S.M.; Samson, R.A.; Hazinski, M.F.; Atkins, D.L.; Berg, M.D.; de Caen A.R.; Fink, E.L.; Freid, E.B.; Hickey, R.W.; Marino, B.S.; Nadkarni,

V.M.; Proctor, L.T.; Qureshi, F.A.; Sartorelli, K.; Topjian, A.; Van der Jagt E.W.; Zaritsky, A.L. Part 14: Pediatric advanced life support: 2010 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation, 2010, 122(18 Suppl 3), S876-S908.

[19] American College of Obstetricians and Gynecologists: Task force on hypertension in pregnancy. Washington, DC. Obstet. Gynecol., 2013, 122(5), 1122-1131.

[20] American Regent: Magnesium sulfate injection, USP Safety data sheet according to Occupational Safety and Health Administration(OSHA) Hazard Communication Standard Rule- 29 CFR 1910.1200 and the Canadian Hazardous Products Act and the Federal Register, 2012 March 26, 77(58), Page 1 of 8. Rules and Regulations Revision Date: 11/10/2015 Date of issue: 11/10/2015.

[21] Mohammadnia, M.; Solgi, G.; Ranjbar, M.; Shahrestani, T.; Edalat, R.; Razavi, A.; Nikbin, B.; Pourmand, G.; Amirzargar, M.; Sarafnejad, A.; Amirzargar, A.A. Serum levels of interleukin (IL)-10, IL-17, transforming growth factor (TGF)-β1, and interferon-γ cytokines and expression levels of IL-10 and TGF-β1 genes in renal allograft recipients after donor bone marrow cell infusion. Transplant Proc., 2011, 43(2), 495-499.

[22] Yeh, P.; Emary, K.; Impey, L. The relationship between umbilical cord arterial pH and serious adverse neonatal outcome: Analysis of 51,519 consecutive validated samples. BJOG, 2012, 119, 824-831

[23] Conway, J.M.; Walsh, B.H.; Boylan, G.B.; Murray, D.M. Mild hypoxic ischaemic encephalopathy and long term neurodevelopmental outcome - A systematic review. Early Hum. Dev., 2018, 120, 80-87.

[24] Herrera-Marschitz, M.; Perez-Lobos, R.; Lespay-Rebolledo, C.; Tapia-Bustos, A.; Casanova-Ortiz, E.; Morales, P.; Valdes, J.L.; Bustamante, D.; Cassels, B.K. Targeting sentinel proteins and extrasynaptic glutamate receptors: A therapeutic strategy for preventing the effects elicited by perinatal asphyxia? Neurotox. Res., 2018, 33(2), 461-473.